BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32090329)

  • 1. Combined insulin-like growth factor binding protein-1/interleukin-6 (Premaquick) versus fetal fibronectin for predicting preterm delivery among women with preterm contractions.
    Asiegbu AC; Eleje GU; Ibeneme EM; Onyegbule OA; Chukwu LC; Egwim AV; Okonko CO; Eze SC; Eke AC
    Int J Gynaecol Obstet; 2020 May; 149(2):171-177. PubMed ID: 32090329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of a combined insulin-like growth factor-binding protein-1/interleukin-6 test (Premaquick) in predicting delivery in women with threatened preterm labor.
    Eleje GU; Ezugwu EC; Eke AC; Eleje LI; Ikechebelu JI; Ezebialu IU; Obiora CC; Nwosu BO; Ezeama CO; Udigwe GO; Okafor CI; Ezugwu FO
    J Perinat Med; 2017 Nov; 45(8):915-924. PubMed ID: 28236632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Fetal Fibronectin and Phosphorylated Insulin-Like Growth Factor Binding Protein-1 Testing to Predict Preterm Delivery in Symptomatic Women: A 10-Year Retrospective Study.
    Chen MX; Dansereau J; Hoag GN
    J Obstet Gynaecol Can; 2020 Aug; 42(8):971-976. PubMed ID: 32345553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of preterm delivery in symptomatic women using PAMG-1, fetal fibronectin and phIGFBP-1 tests: systematic review and meta-analysis.
    Melchor JC; Khalil A; Wing D; Schleussner E; Surbek D
    Ultrasound Obstet Gynecol; 2018 Oct; 52(4):442-451. PubMed ID: 29920825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the quantitative fetal fibronectin test and PAMG-1 test for the prediction of spontaneous preterm birth in patients with signs and symptoms suggestive of preterm labor.
    Ravi M; Beljorie M; El Masry K
    J Matern Fetal Neonatal Med; 2019 Dec; 32(23):3909-3914. PubMed ID: 29807458
    [No Abstract]   [Full Text] [Related]  

  • 6. Predictive performance of PAMG-1 vs fFN test for risk of spontaneous preterm birth in symptomatic women attending an emergency obstetric unit: retrospective cohort study.
    Melchor JC; Navas H; Marcos M; Iza A; De Diego M; Rando D; Melchor I; Burgos J
    Ultrasound Obstet Gynecol; 2018 May; 51(5):644-649. PubMed ID: 28850753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of rapid bedside tests for phosphorylated insulin-like growth factor-binding protein 1 and fetal fibronectin to predict preterm birth.
    Tripathi R; Tyagi S; Mala YM; Singh N; Pandey NB; Yadav P
    Int J Gynaecol Obstet; 2016 Oct; 135(1):47-50. PubMed ID: 27388033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour.
    Audibert F; Fortin S; Delvin E; Djemli A; Brunet S; Dubé J; Fraser WD
    J Obstet Gynaecol Can; 2010 Apr; 32(4):307-12. PubMed ID: 20500936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of rapid phIGFBP-I assay for predicting preterm labor in symptomatic patients.
    Cooper S; Lange I; Wood S; Tang S; Miller L; Ross S
    J Perinatol; 2012 Jun; 32(6):460-5. PubMed ID: 21997470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador.
    Díaz J; Chedraui P; Hidalgo L; Medina M
    J Matern Fetal Neonatal Med; 2009 Feb; 22(2):89-93. PubMed ID: 19085632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of cervical interleukin-6 and -8, phosphorylated insulin-like growth factor-binding protein-1 and transvaginal cervical ultrasonography in assessment of the risk of preterm birth.
    Kurkinen-Räty M; Ruokonen A; Vuopala S; Koskela M; Rutanen EM; Kärkkäinen T; Jouppila P
    BJOG; 2001 Aug; 108(8):875-81. PubMed ID: 11510716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of preterm delivery among women with threatened preterm labor.
    Eroglu D; Yanik F; Oktem M; Zeyneloglu HB; Kuscu E
    Gynecol Obstet Invest; 2007; 64(2):109-16. PubMed ID: 17339775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation.
    Varley-Campbell J; Mújica-Mota R; Coelho H; Ocean N; Barnish M; Packman D; Dodman S; Cooper C; Snowsill T; Kay T; Liversedge N; Parr M; Knight L; Hyde C; Shennan A; Hoyle M
    Health Technol Assess; 2019 Mar; 23(13):1-226. PubMed ID: 30917097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative fetal fibronectin and cervical length in symptomatic women: results from a prospective blinded cohort study
    Levine LD; Downes KL; Romero JA; Pappas H; Elovitz MA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3792-3800. PubMed ID: 29727248
    [No Abstract]   [Full Text] [Related]  

  • 15. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study.
    Tanir HM; Sener T; Yildiz Z
    Clin Exp Obstet Gynecol; 2008; 35(1):61-4. PubMed ID: 18390084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effectiveness of foetal fibronectin as a predictor of preterm birth in symptomatic preterm labour women.
    Jun SY; Lee JY; Kim HM; Kim MJ; Cha HH; Seong WJ
    BMC Pregnancy Childbirth; 2019 Jul; 19(1):241. PubMed ID: 31296172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin.
    Liong S; Di Quinzio MK; Fleming G; Permezel M; Rice GE; Georgiou HM
    BJOG; 2015 Feb; 122(3):370-9. PubMed ID: 25056135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of cervical length, fetal fibronectin, phIGFBP-1, and cytokines in spontaneous preterm birth up to 14 days from sampling.
    Hadži-Lega M; Markova AD; Stefanovic M; Tanturovski M
    J Perinat Med; 2015 Sep; 43(5):545-51. PubMed ID: 25503663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical markers predicting pre-term delivery in symptomatic patients: phosphorylated insulin-like growth factor binding protein-1 and fetal fibronectin.
    Riboni F; Vitulo A; Dell'avanzo M; Plebani M; Battagliarin G; Paternoster D
    Arch Gynecol Obstet; 2011 Dec; 284(6):1325-9. PubMed ID: 21274721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.
    Bruijn MM; Vis JY; Wilms FF; Oudijk MA; Kwee A; Porath MM; Oei G; Scheepers HC; Spaanderman ME; Bloemenkamp KW; Haak MC; Bolte AC; Vandenbussche FP; Woiski MD; Bax CJ; Cornette JM; Duvekot JJ; Nij Bijvank BW; van Eyck J; Franssen MT; Sollie KM; van der Post JA; Bossuyt PM; Opmeer BC; Kok M; Mol BW; van Baaren GJ
    Eur J Obstet Gynecol Reprod Biol; 2016 Nov; 206():220-224. PubMed ID: 27750180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.